BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/10/2021 1:44:23 AM | Browse: 260 | Download: 444
 |
Received |
|
2021-06-22 05:23 |
|
Peer-Review Started |
|
2021-06-22 05:28 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-07-26 07:47 |
|
Revised |
|
2021-07-28 09:09 |
|
Second Decision |
|
2021-08-26 03:28 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-08-27 06:03 |
|
Articles in Press |
|
2021-08-27 06:03 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-09-12 10:23 |
|
Typeset the Manuscript |
|
2021-11-02 07:31 |
|
Publish the Manuscript Online |
|
2021-11-10 01:44 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Emergency Medicine |
| Manuscript Type |
Observational Study |
| Article Title |
Presepsin as a biomarker for risk stratification for acute cholangitis in emergency department: A single-center study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Han-Yu Zhang, Zhao-Qing Lu, Guo-Xing Wang, Miao-Rong Xie and Chun-Sheng Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81773931 |
| Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support “Yanfan” Project |
ZYLX201802 |
|
| Corresponding Author |
Chun-Sheng Li, PhD, Professor, Department of Emergency Medicine, Beijing Friendship Hospital, Capital Medical University, No. 95 Yong-an Road, Xicheng District, Beijing 100050, China. lcscyyy@163.com |
| Key Words |
C-reactive protein; Procalcitonin; Presepsin; Acute cholangitis; Risk stratification |
| Core Tip |
Although the mortality rate in acute cholangitis has decreased notably due to early drainage and antibiotic use, it remains higher in severe cholangitis. Early identification of severe cholangitis can reduce the mortality of patients with severe cholangitis. Presepsin is a promising biomarker for the early diagnosis and prognosis of bacterial infections. In this study, presepsin was found to be superior to white blood cells, C-reactive protein, procalcitonin, and total bilirubin in predicting positive blood culture and assessing risk in patients with acute cholangitis in the emergency department. |
| Publish Date |
2021-11-10 01:44 |
| Citation |
Zhang HY, Lu ZQ, Wang GX, Xie MR, Li CS. Presepsin as a biomarker for risk stratification for acute cholangitis in emergency department: A single-center study. World J Clin Cases 2021; 9(32): 9857-9868 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i32/9857.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i32.9857 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
